These educational Clinical Clips will review HIV and common comorbidity data presented at the 24th International AIDS Conference.
Launch Date: July 30, 2022
ACPE Release Date: July 30, 2022
Expiration Date: June 30, 2023
This educational activity is for healthcare providers who are involved in the clinical care of patients with or at risk for HIV including physicians, physician assistants, registered nurses, nurse practitioners, and pharmacists.
Upon completion of this enduring material, participants should be better able to:
In compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, it is the policy for all accreditors of this accredited continuing education activity as named above to ensure accuracy, balance, objectivity, independence, and scientific rigor in all their educational activities, and to commit to protecting learners from promotion, marketing, and commercial bias. All faculty, planners and others in a position to control continuing education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. This enduring material may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of the accredited providers and Practice Point Communications.
The accredited providers have mitigated and are disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:
PLANNING COMMITTEE DISCLOSURE INFORMATION
Sara Hurtado Bares, MD
Consultant: Gilead Sciences
Funding to Institution for Research Activities: Gilead Sciences, Janssen Therapeutics, ViiV Healthcare
The below planning committee members have nothing to disclose:
UNMC: Valeta Creason-Wahl; Nada Fadul, MD; Heidi Keeler, PhD, RN; Renee Paulin, MSN, RN, CWOCN; Brenda Ram, CMP, CHCP
DU: Amy G. Woods, PharmD, MS Leadership
PPC: Peter Pinkowish; Ashley Richardson
Daniel Kuritzkes, MD
Consultant: Atea, Decoy, Gilead, Janssen, Merck, Moderna, Novartis, Pfizer, Shinogi, ViiV, Virostatics
Research/Investigator: Gilead, Merck, Novartis, Pfizer, Viiv
The University of Nebraska Medical Center, Duquesne University School of Pharmacy, and Practice Point Communications protect the privacy of personal and other information regarding participants and educational collaborators. The University of Nebraska Medical Center, Duquesne University School of Pharmacy, and Practice Point Communications will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME, ANCC, or ACPE.
The University of Nebraska Medical Center, Duquesne University School of Pharmacy, and Practice Point Communications maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:
The Materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without prior written permission.
Supported by an independent educational grant from ViiV Healthcare